Clinical Trial: Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Topical Tacrolimus 0.1% Ointment for Treatment of Cutaneous Crohn's Disease

Brief Summary: An assessment of the efficacy of topical tacrolimus in the treatment of cutaneous crohns disease

Detailed Summary:
Sponsor: University of Aberdeen

Current Primary Outcome: Assessment of standardised digital photography by three independent assessors following the Physicians' Global Severity Scale before and after treatment [ Time Frame: At 12 weeks of treatment, optionally extended to 52 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Global Self Assessment [ Time Frame: 12 weeks, optionally extended to 52 weeks ]
  • Perineal Disease Activity Index [ Time Frame: 12 weeks, optionally extended to 52 weeks ]


Original Secondary Outcome: Same as current

Information By: University of Aberdeen

Dates:
Date Received: November 2, 2010
Date Started:
Date Completion:
Last Updated: November 2, 2010
Last Verified: November 2010